Parabilis Medicines, Inc. Common Stock (PBLS) — Tangible Net Worth Ratio
Parabilis Medicines, Inc. Common Stock (PBLS) has a Tangible Net Worth Ratio of 100.0% as of March 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($244.22 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Parabilis Medicines, Inc. Common Stock net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Parabilis Medicines, Inc. Common Stock Tangible Net Worth Ratio (2024–2024)
This chart shows how Parabilis Medicines, Inc. Common Stock's Tangible Net Worth Ratio has changed across 1 annual periods from 2024 to 2024. As of March 2026, the ratio stands at 100.0%, reflecting net assets of $244.22 Million with intangible assets of $0.00 USD. Also explore net asset momentum of Parabilis Medicines, Inc. Common Stock to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Parabilis Medicines, Inc. Common Stock (2024–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Parabilis Medicines, Inc. Common Stock from 2024 to 2024, covering 1 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see how much is Parabilis Medicines, Inc. Common Stock worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | $56.44 Million | $0.00 | $149.25 Million | — |